Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract. ✅
Go to Publication ✅
Journal of dietary supplements (J Diet Suppl ) Vol: 17 Issue 5 Pages: 543-560 Pub: 2020 Epub: 2020 May 13 Authors Skinner CM , Nookaew I , Ewing LE , Wongsurawat T , Jenjaroenpun P , Quick CM , Yee EU , Piccolo BD , ElSohly M , Walker LA , Gurley B , Koturbash I , |
|
|
Comparison of the Effects of Essential Oils from Cannabis sativa and Cannabis indica on Selected Bacteria, Rumen Fermentation, and Methane Production-In Vitro Study. ✅
Go to Publication ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 25 Issue 11 Pages: Pub: 2024 May 28 Epub: 2024 May 28 Authors Tabis A , Szumny A , Bania J , Pacyga K , Lewandowska K , Kupczynski R , |
|
|
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. ✅
Go to Publication ✅
Brain, behavior, and immunity (Brain Behav Immun ) Vol: 82 Issue Pages: 25-35 Pub: 2019 Nov Epub: 2019 Jul 26 Authors Al-Ghezi ZZ , Busbee PB , Alghetaa H , Nagarkatti PS , Nagarkatti M , |
|
|
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. ✅
Go to Publication ✅
Brain, behavior, and immunity (Brain Behav Immun ) Vol: 82 Issue Pages: 25-35 Pub: 2019 Nov Epub: 2019 Jul 26 Authors Al-Ghezi ZZ , Busbee PB , Alghetaa H , Nagarkatti PS , Nagarkatti M , |
|
|
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. ✅
Go to Publication ✅
Brain, behavior, and immunity (Brain Behav Immun ) Vol: 82 Issue Pages: 25-35 Pub: 2019 Nov Epub: 2019 Jul 26 Authors Al-Ghezi ZZ , Busbee PB , Alghetaa H , Nagarkatti PS , Nagarkatti M , |
|
|
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1358626 Pub: 2024 Epub: 2024 Feb 6 Authors Sun M , Zhang F , Lu F , Yu D , Wang Y , Chen P , Liu S , |
|
|
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1358626 Pub: 2024 Epub: 2024 Feb 6 Authors Sun M , Zhang F , Lu F , Yu D , Wang Y , Chen P , Liu S , |
|
|
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1358626 Pub: 2024 Epub: 2024 Feb 6 Authors Sun M , Zhang F , Lu F , Yu D , Wang Y , Chen P , Liu S , |
|
|
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1358626 Pub: 2024 Epub: 2024 Feb 6 Authors Sun M , Zhang F , Lu F , Yu D , Wang Y , Chen P , Liu S , |
|
|
The impact of medical cannabis consumption on the oral flora and saliva. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 16 Issue 2 Pages: e0247044 Pub: 2021 Epub: 2021 Feb 12 Authors Habib G , Steinberg D , Jabbour A , |
|
|
The antimicrobial potential of cannabidiol. ✅
Go to Publication ✅
Communications biology (Commun Biol ) Vol: 4 Issue 1 Pages: 7 Pub: 2021 Jan 19 Epub: 2021 Jan 19 Authors Blaskovich MAT , Kavanagh AM , Elliott AG , Zhang B , Ramu S , Amado M , Lowe GJ , Hinton AO , Pham DMT , Zuegg J , Beare N , Quach D , Sharp MD , Pogliano J , Rogers AP , Lyras D , Tan L , West NP , Crawford DW , Peterson ML , Callahan M , Thurn M , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
